Harold MD - Avid Bioservices Medical Advisor
| CDMO Stock | USD 12.46 0.02 0.16% |
Insider
Harold MD is Medical Advisor of Avid Bioservices
| Address | 14191 Myford Road, Tustin, CA, United States, 92780 |
| Phone | 714 508 6100 |
| Web | https://www.avidbio.com |
Avid Bioservices Management Efficiency
The company has return on total asset (ROA) of (0.0305) % which means that it has lost $0.0305 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.1584) %, meaning that it created substantial loss on money invested by shareholders. Avid Bioservices' management efficiency ratios could be used to measure how well Avid Bioservices manages its routine affairs as well as how well it operates its assets and liabilities. As of the 30th of January 2025, Return On Tangible Assets is likely to drop to -0.4. In addition to that, Return On Capital Employed is likely to drop to -0.07. At this time, Avid Bioservices' Other Assets are very stable compared to the past year. As of the 30th of January 2025, Net Tangible Assets is likely to grow to about 228.8 M, while Return On Tangible Assets are likely to drop (0.40).Similar Executives
| Showing other executives | INSIDER Age | ||
| Behrad Derakhshan | Edgewise Therapeutics | 45 | |
| Ian Clements | Mirum Pharmaceuticals | 55 | |
| Esq JD | Ideaya Biosciences | 52 | |
| Gene Kim | Dyne Therapeutics | 47 | |
| Erick MD | Acrivon Therapeutics, Common | 67 | |
| Bahija Jallal | Immunocore Holdings | 64 | |
| Kristina Masson | Acrivon Therapeutics, Common | 44 | |
| Scott Anderson | Anebulo Pharmaceuticals | N/A | |
| Matthew MD | Ideaya Biosciences | N/A | |
| Francis Conway | Larimar Therapeutics | N/A | |
| Susanna MBA | Dyne Therapeutics | 56 | |
| Joanna Siegall | Cytokinetics | N/A | |
| FAAD MBA | AnaptysBio | 47 | |
| Kari JD | Cytokinetics | N/A | |
| Eric Devroe | Acrivon Therapeutics, Common | 46 | |
| Rex CFA | Anebulo Pharmaceuticals | 64 | |
| Dennis Mulroy | AnaptysBio | 70 | |
| Dr Roberts | Lyra Therapeutics | 56 | |
| Debra Nielsen | Immunocore Holdings | N/A | |
| Alan Russell | Edgewise Therapeutics | 55 | |
| MD MBA | Kalvista Pharmaceuticals | 52 | |
Management Performance
| Return On Equity | -1.16 | ||||
| Return On Asset | -0.0305 |
Avid Bioservices Leadership Team
Elected by the shareholders, the Avid Bioservices' board of directors comprises two types of representatives: Avid Bioservices inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Avid. The board's role is to monitor Avid Bioservices' management team and ensure that shareholders' interests are well served. Avid Bioservices' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Avid Bioservices' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Shelley Fussey, Vice President - Intellectual Property | ||
| Daniel Hart, Chief Officer | ||
| Mark JD, General VP | ||
| Oksana Lukash, Vice People | ||
| Prof Brekken, Medical Advisor | ||
| Harold MD, Medical Advisor | ||
| Prof Schroit, Medical Advisor | ||
| Matthew Kwietniak, Chief Officer | ||
| Richard Richieri, Chief Officer | ||
| Tracy Kinjerski, VP Operations |
Avid Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Avid Bioservices a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -1.16 | ||||
| Return On Asset | -0.0305 | ||||
| Profit Margin | (1.01) % | ||||
| Operating Margin | (0.06) % | ||||
| Current Valuation | 967.17 M | ||||
| Shares Outstanding | 63.96 M | ||||
| Shares Owned By Insiders | 1.13 % | ||||
| Shares Owned By Institutions | 98.87 % | ||||
| Number Of Shares Shorted | 11.62 M | ||||
| Price To Earning | 10.76 X |
Pair Trading with Avid Bioservices
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Avid Bioservices position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Avid Bioservices will appreciate offsetting losses from the drop in the long position's value.Moving together with Avid Stock
| 0.75 | BMY | Bristol Myers Squibb Earnings Call This Week | PairCorr |
Moving against Avid Stock
| 0.78 | INZY | Inozyme Pharma | PairCorr |
| 0.78 | NKTX | Nkarta Inc | PairCorr |
| 0.77 | PDSB | PDS Biotechnology Corp | PairCorr |
| 0.75 | JNJ | Johnson Johnson | PairCorr |
| 0.73 | PFE | Pfizer Inc Earnings Call This Week | PairCorr |
The ability to find closely correlated positions to Avid Bioservices could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Avid Bioservices when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Avid Bioservices - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Avid Bioservices to buy it.
The correlation of Avid Bioservices is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Avid Bioservices moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Avid Bioservices moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Avid Bioservices can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Avid Bioservices. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. To learn how to invest in Avid Stock, please use our How to Invest in Avid Bioservices guide.You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Avid Bioservices. If investors know Avid will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Avid Bioservices listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.80) | Earnings Share (2.41) | Revenue Per Share | Quarterly Revenue Growth 0.065 | Return On Assets |
The market value of Avid Bioservices is measured differently than its book value, which is the value of Avid that is recorded on the company's balance sheet. Investors also form their own opinion of Avid Bioservices' value that differs from its market value or its book value, called intrinsic value, which is Avid Bioservices' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Avid Bioservices' market value can be influenced by many factors that don't directly affect Avid Bioservices' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Avid Bioservices' value and its price as these two are different measures arrived at by different means. Investors typically determine if Avid Bioservices is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Avid Bioservices' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.